Review paper

Chemotherapy‐induced peripheral neuropathy: A current review

Volume: 81, Issue: 6, Pages: 772 - 781
Published: Jun 1, 2017
Abstract
Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting side effect experienced by patients receiving treatment for cancer. Approximately 30 to 40% of patients treated with neurotoxic chemotherapy will develop CIPN, and there is considerable variability in its severity between patients. It is often sensory‐predominant with pain and can lead to long‐term morbidity in survivors. The prevalence and burden of CIPN late effects...
Paper Details
Title
Chemotherapy‐induced peripheral neuropathy: A current review
Published Date
Jun 1, 2017
Volume
81
Issue
6
Pages
772 - 781
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.